Next Article in Journal
Antimicrobial Susceptibility Profile of Rare Anaerobic Bacteria
Next Article in Special Issue
Unraveling the Role of Metals and Organic Acids in Bacterial Antimicrobial Resistance in the Food Chain
Previous Article in Journal
QSAR Studies, Molecular Docking, Molecular Dynamics, Synthesis, and Biological Evaluation of Novel Quinolinone-Based Thiosemicarbazones against Mycobacterium tuberculosis
Previous Article in Special Issue
Extended Spectrum β-Lactamase-Producing Escherichia coli from Poultry and Wild Birds (Sparrow) in Djelfa (Algeria), with Frequent Detection of CTX-M-14 in Sparrow
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Communication

KPC-Producing Enterobacterales from Douro River, Portugal—Persistent Environmental Contamination by Putative Healthcare Settings

by
Josman Dantas Palmeira
1,2,3,4,5,*,
Inah do Arte
2,
Mai Muhammed Ragab Mersal
1,2,3,
Catarina Carneiro da Mota
2 and
Helena Maria Neto Ferreira
1,2,3
1
UCIBIO—Applied Molecular Biosciences Unit, REQUIMTE, University of Porto, 4050-313 Porto, Portugal
2
Laboratory of Microbiology, Biological Sciences Department, Faculty of Pharmacy, University of Porto, 4050-313 Porto, Portugal
3
Associate Laboratory i4HB-Institute for Health and Bioeconomy, University of Porto, 4050-313 Porto, Portugal
4
CESAM—Centre for Environmental and Marine Studies, University of Aveiro, 3810-193 Aveiro, Portugal
5
PICTIS—International Platform for Science, Technology and Innovation in Health, University of Aveiro (Portugal) & FIOCRUZ, Rio de Janeiro 1040-360, Brazil
*
Author to whom correspondence should be addressed.
Antibiotics 2023, 12(1), 62; https://doi.org/10.3390/antibiotics12010062
Submission received: 6 December 2022 / Revised: 22 December 2022 / Accepted: 28 December 2022 / Published: 29 December 2022
(This article belongs to the Special Issue Environmental Hotspots and Drivers of Antimicrobial Resistance)

Abstract

:
Carbapenemase-producing Enterobacterales (CPE) are a growing concern, representing a major public health threat to humans, especially in healthcare settings. In the present study, we evaluated the persistent contamination by carbapenem-resistant Enterobacterales in water from Douro River, Portugal. KPC-producing Enterobacterales were detected in five water samples separated chronologically by 15 days each. Susceptibility testing was performed by disk-diffusion-method according to Clinical and Laboratory Standards Institute (CLSI), phenotypic carbapenemase activity was evaluated by carbapenem inactivation method, presumptive identification of the isolates was performed by CHROMagar orientation and confirmed by API-20E. Carbapenemase genes were screened by PCR and the clonality of all isolates was assessed by XbaI-Pulsed Field Gel Electrophoresis (PFGE). Fifteen KPC-producing Enterobacterales isolates were selected, identified as multidrug-resistant and showed a resistance profile to non-beta-lactam antibiotics: sulfamethoxazole + trimethoprim (7/15), ciprofloxacin (3/15), fosfomycin (3/15) and chloramphenicol (2/15). Isolates were identified as (6) Escherichia coli and (9) Klebsiella pneumoniae. Our results suggest a punctual contamination with KPC-producing Enterobacterales continued through the time. The absence of clonality between the isolates suggests a circulation of mobile genetic element harbouring KPC gene in the origin of contamination. This work provides a better understanding on the impacts of water pollution resulting from human activities on aquatic environments.

1. Introduction

The emergence of carbapenemase-producing Enterobacterales (CPE) has been identified in recent years as one of the major public-health concerns over the last decade. Carbapenems constitute the last-resort class of antibiotics for nosocomial infections, as in some cases of infection there are very limited treatment options available, being associated with mortality rates that usually exceed 40% [1,2,3,4]. CPE are no longer restricted to healthcare settings, being detected in different ecological niches, such as river waters [5].
In Portugal, KPC prevails over other carbapenemases, with KPC-2 being the most prevalent in northern Portugal and KPC-3 being more associated with healthcare settings [6,7,8].
In 2015, as result of multidrug-resistant pathogens, particularly Klebsiella pneumoniae carbapenemase-producing Enterobacterales (KPC-E), approximately 33,000 people died in Europe. Nowadays, KPC-E is a concern due to the high level of endemicity observed in various areas worldwide, being considered as an urgent threat and one of the biggest global public-health challenges [9].
It is known that there are several connections between the environmental, human and animal compartments that allows for the movement of bacteria, as well as mobile genetic elements and antibiotic resistance [10]. The aquatic environment is often exposed to discharges from various sources, through inadequate handling in agriculture, healthcare settings and industry, collecting biological and chemical contaminants. This allows this ecosystem to perform as a vehicle for antibiotic-resistant bacteria and antibiotic resistance genes that circulate and spread in the environment, reaching and affecting humans [11,12]. It is worth noting that river ecosystems are very relevant, playing key roles in ecosystem functions such as drinking water, food, agriculture, animal production and leisure activities [13].
Presently, there are few epidemiologic studies regarding CPE recovered from rivers. The aim of this study was to explore the presence of CPE in the ecosystem of Douro river, an important river in the Porto metropolitan area and hence with a considerable anthropogenic impact and scarce contribution of animal faecal contaminants.

2. Results

2.1. Carbapenemase-Producing Enterobacterales

2.1.1. Identification and Antimicrobial Resistance Phenotypes

KPC-producing Enterobacterales were selected in all five water samples analysed (Table 1). Isolates were identified as six Escherichia coli and nine Klebsiella pneumoniae. All identified bacteria presented were resistant to meropenem and were multi-drug resistant (MDR) according to the definition by Magiorakos et al. [14]. A substantial proportion of isolates showed reduced susceptibility to non-beta-lactam antibiotics: sulfamethoxazole + trimethoprim (7/15, 46.7%), ciprofloxacin (3/15, 20%), fosfomycin (3/15, 20%) and chloramphenicol (2/15, 13.3%). No resistance was observed for tobramycin and netilmicin, with all isolates displaying a profile of susceptibility or intermediate.

2.1.2. Carbapenemases and ESBL

Fifteen isolates producing carbapenemases were confirmed by the carbapenem inactivation method (CIM) and the carbapenemase phenotype was due to the presence of blaKPC genes (15/15). No other carbapenemase genes were detected.
More, all of the isolates additionally carried 1 to 3 of the most prevalent genes of ESBL-producing bacteria. Seven isolates carried blaCTX-M group 2 (7/15, 46.7%), blaTEM was detected in six isolates (6/15, 40%) and blaOXA in four isolates (4/15, 26.7%). Both blaCTX-M group 9 and blaSHV were not detected in any of the isolates.

2.1.3. Clonal Relation of KPC-Producing Enterobacterales

No clonal relation was detected in the E. coli or in the K. pneumoniae evaluated (Figure S1). With exception of 3 E. coli isolates with similar pattern, which were isolated in the times D0, D30 and D60.

3. Discussion

Nowadays, anthropogenic activities may be one of the biggest reasons behind the dissemination of carbapenem resistance [15]. In this study, we describe the presence of KPC-producing Enterobacterales, in water, over time in Douro River, Vila Nova de Gaia, for 2 months.
CPE are more confined to healthcare settings, including occurrences of outbreaks, however, reports of these Enterobacterales have been increasingly reported in the environment [16]. All of the 15 isolates detected were classified as MDR, showing resistance to three or more classes of antibiotics in addition to meropenem resistance, which highlights an alarming resistance of these Enterobacterales strains. These MDR Enterobacterales are a public health concern due to their therapeutic importance, as the antibiotics to which they are resistant are some of the main therapeutic choices in the hospitals, particularly carbapenem resistant, which is mostly by transference of blaKPC [17,18]. These isolates were identified as 6 E. coli and 9 K. pneumoniae, all of them carrying blaKPC. As expected, blaKPC prevalence was higher in K. pneumoniae than E. coli. Data from the literature reports that Klebsiella spp. and E. coli are the most common carbapanemase producing Enterobacterales isolated from rivers and blaKPC the most prevalent in Europe [3,19], which is in line with our results.
K. pneumoniae is one of the pathogens that were given the highest “priority status”, due to its potential drug resistance, including carbapenems [19]. In Portugal, an increasing trend of carbapenem resistance in K. pneumoniae has been described, evolving from 5.2% in 2016 to 11.6% in 2020, as reported by the European Centre for Disease Prevention and Control (ECDC) [20]. KPC-producing K. pneumoniae were the most prevalent in our study (9/15). Isolates harbouring these gene seem to be widespread in Portuguese hospitals [6,7]. Thus, the presence of blaKPC-harbouring K. pneumoniae in this study is in line with the epidemiology reported in Portuguese healthcare settings, which suggests an anthropogenic origin as the source of contamination.
E. coli are predominantly harmless bacteria that colonize the normal gut flora of humans, yet they are genetically diverse bacteria than can lead to extraintestinal infections [21,22]. Thus, the presence of E. coli resistant to carbapenems may severely affect human health, since it is known its capacity to carry several virulence factors and genes that are not present in strains belonging to commensal strains phylogroups [22]. The occurrence of E. coli KPC-producing strains in the aquatic environment is a worry, being distributed worldwide, although it is scarce, and it is described in countries with high rates of this carbapenemase in K. pneumoniae [18]. The emergence of blaKPC in E. coli has been linked to many mechanisms, such as plasmid exchange with other Enterobacterales, the global spread of genetically related strains and transpositional events in the species [18]. Therefore, the spread of E. coli carbapenem-resistant has severe implications in infection control, once compared with other CPE, since E. coli is a common bacteria in the community and healthcare settings and is easily transmitted.
KPC-producing Enterobacterales have been recurrently reported in hospitals sewage [5,16] and areas where industry is developed, such as agroindustry [3]. However, in our study, in a location as our sampling site, which is an important touristic spot where none of the above activities are practiced near, it is unusual and worrisome to find these reports. Fifteen KPC-producing Enterobacterales isolates were detected in this work with no clonal relationship, away from healthcare settings. The results suggest that the persistence of KPC-producing Enterobacterales was not related to clonal persistence. PFGE analysis showed the absence of a clonal relationship in the 15 isolates, which leads us to believe in the existence of a mobile genetic element responsible for the transmission of blaKPC between the different isolates. KPC-producing bacteria are one of the biggest challenges in healthcare settings worldwide [23]. The description of this public health threat in urban river waters, suggests environmental contamination by accidental healthcare setting sewage, once KPC-producing bacteria are characteristic of healthcare associated intestinal colonization. Our results suggest a punctual contamination with KPC-producing Enterobacterales continued through the time. The absence of clonality between the isolates suggests a circulation of mobile genetic element harbouring KPC gene in the origin of contamination. Gut colonization of the community population does not show this kind of threats and contamination of other zones of the river show contamination with coliforms but without expression of carbapenemases [24,25,26,27].

4. Materials and Methods

4.1. Sampling and Bacterial Isolation

Chronologically separated by 15 days (D0, D15, D30, D45, D60), five samples of water of Douro River were collected in the same place in Vila Nova de Gaia in 2021, from January to March.
The samples were stored directly in sterile glass bottles, held in the refrigerator and analysed shortly after collection (1 to 3 h).
We filtered 100 mL of the water samples, in duplicate, through sterile cellulose acetate membranes with 0.2 μm pore size (Frisenette, Knebel, Denmark) and placed them in MacConkey Agar (Liofilchem, Roseto degli Abruzzi, Italy) supplemented with meropenem (MRP, 0.5 µg/mL, Sigma-Aldrich, Darmstadt, Germany) to select carbapenem-resistant isolates [28]. Thereafter, the plates were incubated overnight at 37 °C. MacConkey Agar (Liofilchem, Roseto degli Abruzzi, Italy) without antibiotic, was used as growth control and control of the culture media was accomplished using Escherichia coli ATCCC 25922, a control strain.

4.2. Bacterial Identification and Antimicrobial Susceptibility Testing

One colony per morphology was picked from selective media onto the antibiotic-selection plate and incubated at 37 °C for 24 h.
The antimicrobial resistance profiles of the isolated bacteria were evaluated with 17 antibiotics by the agar diffusion method, according to Clinical and Laboratory Standards Institute (CLSI) [29]. Using antibiotic disks (Oxoid, Basingstoke, UK and Liofilchem, Roseto degli Abruzzi, Italy) for the following antibiotics: amoxicillin (AML, 10 μg), amoxicillin and clavulanic acid (AMC, 30 μg), aztreonam (ATM, 30 μg), cefepime (FEP, 30 μg), cefotaxime (CTX, 30 μg), cefoxitin (FOX, 30 μg), ceftazidime (CAZ, 30 μg), meropenem (MRP, 10 μg), nitrofurantoin (FUR, 300 μg), ciprofloxacin (CIP, 5 μg), fosfomycin (FOT, 200 μg), tobramycin (TOB, 10 μg) tetracycline (TET, 30 μg), levofloxacin (LEV, 5 μg), chloramphenicol (CHL, 30 μg), sulfamethoxazole + trimethoprim (SXT, 25 μg) and netilmicin (NET, 10 μg).
Phenotypic carbapenemase activity was evaluated by carbapenem inactivation method (CIM) which was performed on isolates showing reduced susceptibility to carbapenems. For a quick presumptive identification, CHROMagar Orientation (CHOROMagar, Paris, France) was performed and this identification was further confirmed with API 20E (Biomérieux, Marcy l’Etoile, France).

4.3. Beta-Lactamase Genes Screening

The bacterial DNA of carbapenem-resistant isolates was screened for carbapenemase genes. PCRs multiplexes were performed, which include the most prevailing acquired carbapenemase genes (blaKPC, blaOXA-48, blaNDM, blaVIM and blaIMP). The PCR was executed under the followed conditions: 10 min at 94 °C, followed of 36 cycles of 30 s at 94 °C, 40 s at 52 °C and 50 s at 72 °C and a final extension of 5 min at 72 °C [30], using Super Hot Master Mix (Bioron, Römerberg, Germany).
Additionally, PCR multiplex was also performed for the most prevailing ESBL genes, blaCTX-M group 1, blaCTX-M group 2, blaCTX-M group 8, blaCTX-M group 9, blaCTX-M group 25, blaTEM, blaOXA and blaSHV. For blaCTX-M, the amplification conditions were initial denaturation at 94 °C for 5 min, 30 cycles of 94 °C for 25 s, 52 °C for 40 s and 72 °C for 50 s and 6 min at 72 °C [31]. Regarding blaTEM, blaOXA and blaSHV, the amplification was carried out at 94 °C for 10 min, 30 cycles of 94 °C for 40 s, 60 °C for 40 s, 72 °C for 1 min and a final elongation at 72 °C for 7 min [32].

4.4. Pulsed-Field Gel Electrophoresis

For clonality evaluation, PFGE was performed according to PulseNet USA standard protocol, through a CHIF-DR III system (BIO-RAD-U.S.A., Hercules, CA, USA) using 10 s as initial time and 40 s as final time for 21 h of running, after digestion of immobilized DNA with XbaI restriction enzyme (Bioron, Römerberg, Germany) [33].

5. Conclusions

In conclusion, our findings highlight the importance of AMR research in environmental samples and further analysis should be made to detect the possible causes of the presence and persistence of CPE in single specific location of this urban river. These results suggest a focal contamination, since it prevailed in the five samples, collected chronologically and separated by 15 days.
This work shows the relevance of this finding as a powerful biological marker of focal contamination and their persistence in river environments, by putative healthcare setting wastewaters, which may be related to the location and circulation of these genes by mobile genetic elements. These results alert to the need to expand the monitorization of carbapenemases dispersion in bacteria, particularly in natural environments exposed to anthropogenic pressures.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/antibiotics12010062/s1, Figure S1: PFGE fingerprint of KPC-producing E. coli (a) and K. pneumoniae (b) from river Douro waters.

Author Contributions

Conceptualization, H.M.N.F. and J.D.P.; methodology, H.M.N.F. and J.D.P.; software, J.D.P.; validation, H.M.N.F. and J.D.P. formal analysis, I.d.A., C.C.d.M., J.D.P. and H.M.N.F.; investigation, I.d.A., C.C.d.M. and M.M.R.M.; resources, H.M.N.F.; data curation, H.M.N.F. and J.D.P.; writing—original draft preparation, C.C.d.M.; writing—review and editing, J.D.P. and H.M.N.F.; supervision, H.M.N.F. and J.D.P.; project administration, H.M.N.F.; funding acquisition, H.M.N.F. All authors have read and agreed to the published version of the manuscript.

Funding

This work was supported by the Applied Molecular Biosciences Unit—UCIBIO/REQUIMTE (UIDP/04378/2020 and UIDB/04378/2020), which is financed by national funds from FCT and the Associate Laboratory, Institute for Health and Bioeconomy—i4HB (LA/P/0140/2020). J.D.P. thanks the strategic funding to CESAM (UIDP/50017/2020+UIDB/50017/2020+LA/P/0094/2020), through national funds. H.M.N.F. and J.D.P. thanks the projects project FERMOPSY (EXPL/SAU-NUT/0370/2021) financed by national funds from FCT/MCTES and AgriFood XXI I&D&I project (NORTE-01-0145-FEDER-000041) co-financed by European Regional Development Fund, through the NORTE 2020 (Programa Operacional Regional do Norte 2014/2020).

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Not applicable.

Acknowledgments

We thank Cristina Pinto da Costa for the technical support.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Logan, L.K.; Weinstein, R.A. The Epidemiology of Carbapenem-Resistant Enterobacteriaceae: The Impact and Evolution of a Global Menace. J. Infect. Dis. 2017, 215 (Suppl. S1), S28–S36. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  2. Cahill, N.; O’Connor, L.; Mahon, B.; Varley, A.; McGrath, E.; Ryan, P.; Cormican, M.; Brehony, C.; Jolley, K.A.; Maiden, M.C.; et al. Hospital Effluent: A Reservoir for Carbapenemase-Producing Enterobacterales? Sci. Total Environ. 2019, 672, 618–624. [Google Scholar] [CrossRef] [PubMed]
  3. Teixeira, P.; Tacão, M.; Henriques, I. Occurrence and Distribution of Carbapenem-Resistant Enterobacterales and Carbapenemase Genes Along a Highly Polluted Hydrographic Basin. Environ. Pollut. 2022, 300, 118958. [Google Scholar] [CrossRef] [PubMed]
  4. Rima, M.; Oueslati, S.; Dabos, L.; Daaboul, D.; Mallat, H.; Raad, E.B.; Achkar, M.; Mawlawi, O.; Bernabeu, S.; Bonnin, R.; et al. Prevalence and Molecular Mechanisms of Carbapenem Resistance among Gram-Negative Bacilli in Three Hospitals of Northern Lebanon. Antibiotics 2022, 11, 1295. [Google Scholar] [CrossRef]
  5. Loudermilk, E.M.; Kotay, S.M.; Barry, K.E.; Parikh, H.I.; Colosi, L.M.; Mathers, A.J. Tracking Klebsiella Pneumoniae Carbapenemase Gene as an Indicator of Antimicrobial Resistance Dissemination from a Hospital to Surface Water Via a Municipal Wastewater Treatment Plant. Water Res. 2022, 213, 118151. [Google Scholar] [CrossRef]
  6. Lopes, E.; Saavedra, M.J.; Costa, E.; de Lencastre, H.; Poirel, L.; Aires-De-Sousa, M. Epidemiology of Carbapenemase-Producing Klebsiella pneumoniae in Northern Portugal: Predominance of KPC-2 and OXA-48. J. Glob. Antimicrob. Resist. 2020, 22, 349–353. [Google Scholar] [CrossRef]
  7. Aires-de-Sousa, M.; de la Rosa, J.M.O.; Gonçalves, M.; Pereira, A.; Nordmann, P.; Poirel, L. Epidemiology of Carbapenemase-Producing Klebsiella pneumoniae in a Hospital, Portugal. Emerg. Infect. Dis. 2019, 25, 1632–1638. [Google Scholar] [CrossRef] [Green Version]
  8. Manageiro, V.; Ferreira, E.; Almeida, J.; Barbosa, S.; Simões, C.; ARSIP; Bonomo, R.A.; Caniça, M. Predominance of KPC-3 in a Survey for Carbapenemase-Producing Enterobacteriaceae in Portugal. Antimicrob. Agents Chemother. 2015, 59, 3588–3592. [Google Scholar] [CrossRef] [Green Version]
  9. Di Bella, S.; Giacobbe, D.R.; Maraolo, A.E.; Viaggi, V.; Luzzati, R.; Bassetti, M.; Luzzaro, F.; Principe, L. Resistance to Ceftazidime/Avibactam in Infections and Colonisations by KPC-Producing Enterobacterales: A Systematic Review of Observational Clinical Studies. J. Glob. Antimicrob. Resist. 2021, 25, 268–281. [Google Scholar] [CrossRef]
  10. Woolhouse, M.; Ward, M.; van Bunnik, B.; Farrar, J. Antimicrobial Resistance in Humans, Livestock and the Wider Environment. Philos. Trans. R. Soc. Lond. B Biol. Sci. 2015, 370, 20140083. [Google Scholar] [CrossRef]
  11. Makowska, N.; Koczura, R.; Mokracka, J. Class 1 Integrase, Sulfonamide and Tetracycline Resistance Genes in Wastewater Treatment Plant and Surface Water. Chemosphere 2016, 144, 1665–1673. [Google Scholar] [CrossRef] [PubMed]
  12. Tacão, M.; Moura, A.; Correia, A.; Henriques, I. Co-Resistance to Different Classes of Antibiotics among ESBL-Producers from Aquatic Systems. Water Res. 2014, 48, 100–107. [Google Scholar] [CrossRef]
  13. Grenni, P. Antimicrobial Resistance in Rivers: A Review of the Genes Detected and New Challenges. Environ. Toxicol. Chem. 2022, 41, 687–714. [Google Scholar] [CrossRef] [PubMed]
  14. Magiorakos, A.P.; Srinivasan, A.; Carey, R.B.; Carmeli, Y.; Falagas, M.E.; Giske, C.G.; Harbarth, S.; Hindler, J.F.; Kahlmeter, G.; Olsson-Liljequist, B.; et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: An international expert proposal for interim standard definitions for acquired resistance. Clin. Microbiol. Infect. 2012, 18, 268–281. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  15. Mills, M.C.; Lee, J. The Threat of Carbapenem-Resistant Bacteria in the Environment: Evidence of Widespread Contamination of Reservoirs at a Global Scale. Environ. Pollut. 2019, 255, 113143. [Google Scholar] [CrossRef]
  16. Jelić, M.; Hrenović, J.; Dekić, S.; Goić-Barišić, I.; Andrašević, A.T. First Evidence of KPC-Producing ST258 Klebsiella pneumoniae in River Water. J. Hosp. Infect. 2019, 103, 147–150. [Google Scholar] [CrossRef]
  17. Homlok, R.; Kiskó, G.; Kovács, A.; Tóth, T.; Takács, E.; Mohácsi-Farkas, C.; Wojnárovits, L.; Szabó, L. Antibiotics in a Wastewater Matrix at Environmentally Relevant Concentrations Affect Coexisting Resistant/Sensitive Bacterial Cultures with Profound Impact on Advanced Oxidation Treatment. Sci. Total Environ. 2021, 754, 142181. [Google Scholar] [CrossRef]
  18. Ripabelli, G.; Sammarco, M.; Scutellà, M.; Felice, V.; Tamburro, M. Carbapenem-Resistant KPC- and TEM-Producing Escherichia coli ST131 Isolated from a Hospitalized Patient with Urinary Tract Infection: First Isolation in Molise Region, Central Italy, July 2018. Microb. Drug Resist. 2020, 26, 38–45. [Google Scholar] [CrossRef]
  19. Hoang, C.Q.; Nguyen, H.D.; Vu, H.Q.; Nguyen, A.T.; Pham, B.T.; Tran, T.L.; Nguyen, H.T.H.; Dao, Y.M.; Nguyen, T.S.M.; Nguyen, D.A.; et al. Emergence of New Delhi Metallo-Beta-Lactamase (NDM) and Klebsiella pneumoniae Carbapenemase (KPC) Production by Escherichia coli and Klebsiella pneumoniae in Southern Vietnam and Appropriate Methods of Detection: A Cross-Sectional Study. BioMed Res. Int. 2019, 2019, 9757625. [Google Scholar] [CrossRef] [Green Version]
  20. ECDC. Country Summaries EARS-Net 2022. EARSS Report (2022). Available online: https://www.ecdc.europa.eu/en/publications-data/antimicrobial-resistance-surveillance-europe-2022-2020-data (accessed on 18 November 2022).
  21. Mahmoud, N.E.; Altayb, H.M.; Gurashi, R.M. Detection of Carbapenem-Resistant Genes in Escherichia coli Isolated from Drinking Water in Khartoum, Sudan. J. Environ. Public Health 2020, 2020, 2571293. [Google Scholar] [CrossRef]
  22. Mesquita, E.; Ribeiro, R.; Silva, C.; Alves, R.; Baptista, R.; Condinho, S.; Rosa, M.; Perdigão, J.; Caneiras, C.; Duarte, A. An Update on Wastewater Multi-Resistant Bacteria: Identification of Clinical Pathogens Such as Escherichia coli O25b:H4-B2-ST131-Producing CTX-M-15 ESBL and KPC-3 Carbapenemase-Producing Klebsiella oxytoca. Microorganisms 2021, 9, 576. [Google Scholar] [CrossRef] [PubMed]
  23. Tesfa, T.; Mitiku, H.; Edae, M.; Assefa, N. Prevalence and Incidence of Carbapenem-Resistant K. pneumoniae Colonization: Systematic Review and Meta-Analysis. Syst. Rev. 2022, 11, 240. [Google Scholar] [CrossRef] [PubMed]
  24. Mota, R.; Pinto, M.; Palmeira, J.; Gonçalves, D.; Ferreira, H. Multidrug-resistant bacteria as intestinal colonizers and evolution of intestinal colonization in healthy university students in Portugal. Access Microbiol. 2020, 3, 000182. [Google Scholar] [CrossRef] [PubMed]
  25. Palmeira, J.D.; do Arte, I.; Cunha, M.V.; Fonseca, C.; Torres, R.T.; Ferreira, H.M.N. ESBL and AmpC producing Enterobacterales in urban waters of Douro River in Portugal—Is the environment a mirror of community intestinal colonization? In Proceedings of the Congress of Microbiology and Biotechnology (Microbiotec ’21), Lisbon, Portugal, 23–26 November 2021. [Google Scholar]
  26. Mota, R.; Pinto, M.; Palmeira, J.; Gonçalves, D.; Ferreira, H. Intestinal microbiota as a reservoir of extended-spectrum-β-lactamase producing Escherichia coli—An exploratory study in healthy university students. J. Glob. Antimicrob. Resist. 2018, 14, 10–11. [Google Scholar] [CrossRef] [PubMed]
  27. Duarte, G.; Mota, R.; Gonçalves, D.; Ferreira, H. Intestinal colonization of residents of long-term care facilities and nursing homes in Braga area with Multidrug-resistant Gram-negatives PS160. Porto Biomed. J. 2017, 2, 234. [Google Scholar] [CrossRef]
  28. Torres, R.T.; Cunha, M.V.; Ferreira, H.; Fonseca, C.; Dantas Palmeira, J. A high-risk carbapenem-resistant Pseudomonas aeruginosa clone detected in red deer (Cervus elaphus) from Portugal. Sci. Total Environ. 2022, 829, 154699. [Google Scholar] [CrossRef]
  29. CLSI. Performance Standards for Antimicrobial Susceptibilty Testing, 32nd ed.; CLSI: Annapolis Junction, MD, USA, 2022. [Google Scholar]
  30. Poirel, L.; Walsh, T.R.; Cuvillier, V.; Nordmann, P. Multiplex PCR for Detection of Acquired Carbapenemase Genes. Diagn. Microbiol. Infect. Dis. 2011, 70, 119–123. [Google Scholar] [CrossRef]
  31. Woodford, N.; Fagan, E.J.; Ellington, M.J. Multiplex PCR for Rapid Detection of Genes Encoding CTX-M Extended-Spectrum β-Lactamases. J. Antimicrob. Chemother. 2006, 57, 154–155. [Google Scholar] [CrossRef] [Green Version]
  32. Dallenne, C.; Da Costa, A.; Decré, D.; Favier, C.; Arlet, G. Development of a Set of Multiplex PCR Assays for the Detection of Genes Encoding Important β-Lactamases in Enterobacteriaceae. J. Antimicrob. Chemother. 2010, 65, 490–495. [Google Scholar] [CrossRef] [Green Version]
  33. Torres, R.T.; Cunha, M.V.; Araujo, D.; Ferreira, H.; Fonseca, C.; Palmeira, J.D. Emergence of Colistin Resistance Genes (mcr-1) in Escherichia coli among Widely Distributed Wild Ungulates. Environ. Pollut. 2021, 291, 118136. [Google Scholar] [CrossRef]
Table 1. Identification of the 15 isolates per sample, bacterial specie, carbapenemase gene, other beta-lactamases and non-beta-lactamases resistance.
Table 1. Identification of the 15 isolates per sample, bacterial specie, carbapenemase gene, other beta-lactamases and non-beta-lactamases resistance.
SampleIsolate IDBacterial SpeciesCarbapenemase GeneOther Beta-LactamasesNon-Beta-Lactam Resistance
D01-MEM-AE. coliblaKPCblaCTX-M-group 2CIP, SXT
D01-MEM-BE. coliblaKPCblaCTX-M-group 2CIP
D01-MEM-DK. pneumoniaeblaKPCblaCTX-M-group 1-
D01-MEM-D(2)E. coliblaKPCblaCTX-M-group 2FOT
D151(2)-MEM-AK. pneumoniaeblaKPCblaTEM, blaOXASXT
D151(2)-MEM-CK. pneumoniaeblaKPCblaCTX-M-group 8SXT
D301(3)-MEM-BE. coliblaKPCblaCTX-M-group 2SXT, FUR
D301(3)-MEM-DK. pneumoniaeblaKPCblaCTX-M-group 2, blaTEM, blaOXA-
D451(4)-MEM-AK. pneumoniaeblaKPCblaTEMFOT
D601(5)-MEM-AK. pneumoniaeblaKPCblaCTX-M-group 1, blaTEM, blaOXACIP, LEV, TET, SXT, CHL, FUR
D601(5)-MEM-BK. pneumoniaeblaKPCblaOXA-
D601(5)-MEM-CK. pneumoniaeblaKPCblaTEMLEV, CHL
D601(5)-MEM-DK. pneumoniaeblaKPCblaCTX-M-group 2, blaTEMSXT
D601(5)-MEM-EE. coliblaKPCblaCTX-M-group 2-
D601(5)-MEM-FE. coliblaKPCblaCTX-M-group 1SXT, FOT
Ciprofloxacin (CIP), levofloxacin (LEV), tetracycline (TET), sulfamethoxazole + trimethoprim (SXT), chloramphenicol (CHL), fosfomycin (FOT) and nitrofurantoin (FUR).
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Dantas Palmeira, J.; do Arte, I.; Ragab Mersal, M.M.; Carneiro da Mota, C.; Ferreira, H.M.N. KPC-Producing Enterobacterales from Douro River, Portugal—Persistent Environmental Contamination by Putative Healthcare Settings. Antibiotics 2023, 12, 62. https://doi.org/10.3390/antibiotics12010062

AMA Style

Dantas Palmeira J, do Arte I, Ragab Mersal MM, Carneiro da Mota C, Ferreira HMN. KPC-Producing Enterobacterales from Douro River, Portugal—Persistent Environmental Contamination by Putative Healthcare Settings. Antibiotics. 2023; 12(1):62. https://doi.org/10.3390/antibiotics12010062

Chicago/Turabian Style

Dantas Palmeira, Josman, Inah do Arte, Mai Muhammed Ragab Mersal, Catarina Carneiro da Mota, and Helena Maria Neto Ferreira. 2023. "KPC-Producing Enterobacterales from Douro River, Portugal—Persistent Environmental Contamination by Putative Healthcare Settings" Antibiotics 12, no. 1: 62. https://doi.org/10.3390/antibiotics12010062

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop